SHINIL PHARMACEUTICAL CO., LTD. · 임원ㆍ주요주주특정증권등소유상황보고서
Report on Specified Securities Owned by Officers and Major Shareholders
6.1
신일제약(주)
20261119
Report on Specified Securities Owned by Officers and Major Shareholders
| To: Securities and Futures Commission | ||
| To: Korea Exchange | ||
| Reporting obligation date: | 2026.11.19 | |
| Report reference date: | 2026.11.19 | |
| ※ The reporting person confirms that ownership of specified securities as of the reference date is accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
| Reporting person: | 홍 성 소 |
| Company Name | 신일제약(주) | ||
| Entity type | KOSDAQ-Listed Company | Company code | 012790 |
| Total Shares Issued | 11,986,415 | ||
| Report Type | Change | Reporting person type | Individual (Domestic) | |
| Name (Entity Name) | Korean | 홍성소 | Chinese characters (English) | 洪 性 昭 |
| Date of Birth or Business Registration No., etc. | 380217 | |||
| Address (Head Office) [Town/District Level Only] | 서울특별시 동대문구 장안벚꽃로 | |||
| Relationship to Issuer | Officer (Registered or Not) | Registered Officer | Position | 회장 |
| Appointment Date | 2024.03.25 | Resignation Date | - | |
| Major Shareholder | - | |||
| Business contact and person in charge | Affiliated company | 신일제약(주) | Department | 경영지원부 |
| Position | Executive Director | Phone Number | 02-221** | |
| Name | 김경희 | Fax number | 02-221** | |
| Email address | **sinilpharm.com | |||
| Report reference date | Specified Securities | Share Certificates | |||
| Number of Specified Securities (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) | ||
| Previous Report | 2024.06.04 | 239,650 | 2.00 | 239,650 | 2.00 |
| This Report | 2026.11.19 | 236,650 | 1.97 | 236,650 | 1.97 |
| Change | -3,000 | -0.03 | -3,000 | -0.03 | |
| Details of Specified Securities | |||||||||
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Participating Bonds | Exchangeable bonds | Depositary receipts | Other | Total | |
| Number of shares | Ratio (%) | ||||||||
| 236,650 | - | - | - | - | - | - | - | 236,650 | 1.97 |
| A | B | C | D | E | F | G | H | ||
| I | |||||||||
| Total Shares Issued (J) | Number of Specified Securities Other Than Shares (B+C+D+E+F+G+H=I) | Ownership ratio (%) | |
| Ownership Ratio of Specified Securities [A+I / J+I-(F+G+H)※] × 100 | Shareholding Ratio (A / J) × 100 | ||
| 11,986,415 | - | 1.97 | 1.97 |
※ Ownership ratio excludes from the denominator only exchangeable bonds exchangeable into shares and depositary receipts, derivative-linked securities, etc. with shares as underlying
| Reason for Report | Change Date* | Type of Specified Securities | Shares Owned (shares) | Acquisition/Disposal Unit Price (KRW)** | Remarks | Trading plan report date | ||
| Before Change | Change | After Change | ||||||
| Gift (-) | 2026.11.19 | Common Stock | 239,650 | -3,000 | 236,650 | - | 수증자 : 홍은찬 | - |
| Total | 239,650 | -3,000 | 236,650 | - | - | |||
* For trades on the securities market, the settlement date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities